Literature DB >> 29246724

Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.

Emanuela Colla1, Giulia Panattoni2, Alessio Ricci2, Caterina Rizzi2, Lucia Rota2, Nicola Carucci2, Verdiana Valvano2, Francesco Gobbo2, Simona Capsoni2, Michael K Lee3, Antonino Cattaneo4.   

Abstract

α-synuclein (αS) is a small protein that self-aggregates into α-helical oligomer species and subsequently into larger insoluble amyloid fibrils that accumulate in intraneuronal inclusions during the development of Parkinson's disease. Toxicity of αS oligomers and fibrils has been long debated and more recent data are suggesting that both species can induce neurodegeneration. However while most of these data are based on differences in structure between oligomer and aggregates, often preassembled in vitro, the in vivo situation might be more complex and subcellular locations where αS species accumulate, rather than their conformation, might contribute to enhanced toxicity. In line with this observation, we have shown that αS oligomers and aggregates are associated with the endoplasmic reticulum/microsomes (ER/M) membrane in vivo and how accumulation of soluble αS oligomers at the ER/M level precedes neuronal degeneration in a mouse model of α-synucleinopathies. In this paper we took a further step, investigating the biochemical and functional features of αS species associated with the ER/M membrane. We found that by comparison with non-microsomal associated αS (P10), the ER/M-associated αS pool is a unique population of oligomers and aggregates with specific biochemical traits such as increased aggregation, N- and C-terminal truncations and phosphorylation at serine 129. Moreover, when administered to murine primary neurons, ER/M-associated αS species isolated from diseased A53T human αS transgenic mice induced neuronal changes in a time- and dose-dependent manner. In fact the addition of small amounts of ER/M-associated αS species from diseased mice to primary cultures induced the formation of beads-like structures or strings of fibrous αS aggregates along the neurites, occasionally covering the entire process or localizing at the soma level. By comparison treatment with P10 fractions from the same diseased mice resulted in the formation of scarce and small puncta only when administered at high amount. Moreover, increasing the amount of P100/M fractions obtained from diseased and, more surprisingly, from presymptomatic mice induced a significant level of neuronal death that was prevented when neurons were treated with ER/M fractions immunodepleted of αS high molecular weight (HMW) species. These data provide the first evidence of the existence of two different populations of αS HMW species in vivo, putting the spotlight on the association to ER/M membrane as a necessary step for the acquisition of αS toxic features.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregates; Endoplasmic reticulum; Microsomes; Neurodegeneration; Oligomers; Parkinson's disease; α-Synuclein

Mesh:

Substances:

Year:  2017        PMID: 29246724      PMCID: PMC6705388          DOI: 10.1016/j.nbd.2017.12.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  9 in total

1.  Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.

Authors:  Iva Stojkovska; Willayat Y Wani; Friederike Zunke; Nandkishore R Belur; Egor A Pavlenko; Nkatha Mwenda; Karan Sharma; Laetitia Francelle; Joseph R Mazzulli
Journal:  Neuron       Date:  2021-11-17       Impact factor: 18.688

Review 2.  Human tyrosine hydroxylase in Parkinson's disease and in related disorders.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hiroshi Ichinose; Kazuto Kobayashi
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

Review 3.  Subcellular localization of alpha-synuclein aggregates and their interaction with membranes.

Authors:  Fabiana Miraglia; Alessio Ricci; Lucia Rota; Emanuela Colla
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 4.  Linking the Endoplasmic Reticulum to Parkinson's Disease and Alpha-Synucleinopathy.

Authors:  Emanuela Colla
Journal:  Front Neurosci       Date:  2019-05-29       Impact factor: 4.677

Review 5.  Microbiome, Parkinson's Disease and Molecular Mimicry.

Authors:  Fabiana Miraglia; Emanuela Colla
Journal:  Cells       Date:  2019-03-07       Impact factor: 6.600

6.  Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy.

Authors:  Lucia Rota; Carolina Pellegrini; Laura Benvenuti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Antonino Cattaneo; Emanuela Colla
Journal:  Transl Neurodegener       Date:  2019-02-06       Impact factor: 8.014

7.  CDNF Protein Therapy in Parkinson's Disease.

Authors:  Henri J Huttunen; Mart Saarma
Journal:  Cell Transplant       Date:  2019-04-04       Impact factor: 4.064

Review 8.  Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson's Disease.

Authors:  Denisse Sepúlveda; Marisol Cisternas-Olmedo; Javiera Arcos; Melissa Nassif; René L Vidal
Journal:  Front Mol Neurosci       Date:  2022-02-17       Impact factor: 5.639

9.  Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation.

Authors:  Giulia Panattoni; Lucia Rota; Emanuela Colla
Journal:  J Vis Exp       Date:  2018-06-26       Impact factor: 1.355

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.